Publications by authors named "William Go"

Claim this Profile
D
Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunities.
Ariane Lozac'hmeur, Tyler Danek, Qidi Yang, Mario G Rosasco, John S Welch, William Y Go

NPJ Precis Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas.
Kedar Kirtane, Maie St John, Harry Fuentes-Bayne, Sandip P Patel, Armen Mardiros, William Y Go

J Clin Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer T-cell therapy: building the foundation for a cure.
Alexander Kamb, William Y Go

F1000Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma.
Frederick L Locke, John M Rossi, Sattva S Neelapu, Caron A Jacobson, David B Miklos, William Y Go

Blood Adv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy.
Pei-Hsuan Chen, Mikel Lipschitz, Jason L Weirather, Caron Jacobson, Philippe Armand, William Go

JCI Insight· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Use of the Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Axicabtagene Ciloleucel in Large B-Cell Lymphoma: A Review.
Frederick L Locke, William Y Go, Sattva S Neelapu

JAMA Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Daniel W Lee, Bianca D Santomasso, Frederick L Locke, Armin Ghobadi, Cameron J Turtle, William Y Go

Biol Blood Marrow Transplant· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.
Frederick L Locke, Armin Ghobadi, Caron A Jacobson, David B Miklos, Lazaros J Lekakis, Andre Goy, William Y Go

Lancet Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T-Cell Therapy in Large B-Cell Lymphoma.
Sattva S Neelapu, Frederick L Locke, William Y Go

N Engl J Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, Lazaros J Lekakis, David B Miklos, Andre Goy, William Y Go

N Engl J Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study.
Michael Crump, Sattva S Neelapu, Umar Farooq, Eric Van Den Neste, John Kuruvilla, William Y Go

Blood· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma.
Frederick L Locke, Sattva S Neelapu, Nancy L Bartlett, Tanya Siddiqi, Julio C Chavez, William Y Go

Mol Ther· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPIRITT: A Randomized, Multicenter, Phase II Study of Panitumumab with FOLFIRI and Bevacizumab with FOLFIRI as Second-Line Treatment in Patients with Unresectable Wild Type KRAS Metastatic Colorectal Cancer.
J Randolph Hecht, Allen Cohn, Shaker Dakhil, Mansoor Saleh, Bilal Piperdi, William Y Go

Clin Colorectal Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEAK: a randomized, multicenter phase II study of panitumumab plus modified fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) or bevacizumab plus mFOLFOX6 in patients with previously untreated, unresectable, wild-type KRAS exon 2 metastatic colorectal cancer.
Lee S Schwartzberg, Fernando Rivera, Meinolf Karthaus, Gianpiero Fasola, Jean-Luc Canon, William Y Go

J Clin Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma membrane Ca(2+) ATPase Atp2b1a regulates bone mineralization in zebrafish.
William Go, Vladimir Korzh

Bone· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TonEBP stimulates multiple cellular pathways for adaptation to hypertonic stress: organic osmolyte-dependent and -independent pathways.
Sang Do Lee, Soo Youn Choi, Sun Woo Lim, S Todd Lamitina, Steffan N Ho, William Y Go

Am J Physiol Renal Physiol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A splenic artery aneurysm that mimics a stromal tumor and causes hematemesis.
Raymond S Tang, Cristina S Wiese, William Y Go

Clin Gastroenterol Hepatol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
atp2b1a regulates Ca(2+) export during differentiation and regeneration of mechanosensory hair cells in zebrafish.
William Go, Dmitri Bessarab, Vladimir Korzh

Cell Calcium· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcineurin-NFATc signaling pathway regulates AQP2 expression in response to calcium signals and osmotic stress.
Song-Zhe Li, Bradley W McDill, Paul A Kovach, Li Ding, William Y Go

Am J Physiol Cell Physiol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zebrafish transgenic Enhancer TRAP line database (ZETRAP).
Benjamin G H Choo, Igor Kondrichin, Sergey Parinov, Alexander Emelyanov, William Go

BMC Dev Biol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NFAT5/TonEBP mutant mice define osmotic stress as a critical feature of the lymphoid microenvironment.
William Y Go, Xuebin Liu, Michelle A Roti, Forrest Liu, Steffan N Ho

Proc Natl Acad Sci U S A· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the cytoskeletal regulatory protein alpha-adducin as a target of T cell receptor signaling.
Qingjun Lu, Xuebin Liu, Jason Trama, Michelle A Roti, William Y Go

Mol Immunol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization and direct comparison of the dimerizer and reverse tet transcriptional control systems.
William Y Go, Steffan N Ho

J Gene Med· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The osmoprotective function of the NFAT5 transcription factor in T cell development and activation.
Jason Trama, William Y Go, Steffan N Ho

J Immunol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis